Publication Month: Jan 2021 | Report Code: TIPRE00008212 | No. of Pages: 145 | Category: Medical Device | Status: Published
GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches. Moreover, these are used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions. The growth of the GMP cytokines market is mainly attributed to the factors such as increase in acceptance of cytokines cancer and autoimmune therapies, and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.
Get more information on this report :
Cytokines play significant role in the regulation of innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate the immune system of cancer patients has been an essential parameter in the treatment of cancer and continues to be a prime contributor to present clinical cancer research. Interferon-alpha is one of the approved cytokines for the adjuvant treatment of refractory malignancies. Several research activities have proved the ability of cytokines to limit tumor cell growth by a direct anti-proliferative or pro-apoptotic activity. Moreover, some cytokines inhibit the tumor growth indirectly by stimulating the cytotoxic activity of immune cells against tumor cells. This effectiveness of cytokines therapies over cancer coupled with increasing prevalence of the disease is likely to drive the market by 2027. According to the World Health Organization, in 2019, approximately 9.6 million deaths across the globe were due to cancer.
Additionally, increasing number of investments and collaborations to develop cytokine therapies over cancer and autoimmune diseases are also expected to accelerate the market growth. For instance, in September 2020, Synthekine Inc. raised US$ 82.0 million through rounds of series funding. The company is engaged in the development of cytokine therapeutics for the treatment of cancer and autoimmune disorders.
Based on type, the GMP cytokines market is segmented into TNF, interleukin, growth factor, and others. The growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is anticipated to register the highest CAGR of 8.7% in the market during the forecast period.
Get more information on this report :
Based on application, the GMP cytokines market is segmented into cell and gene therapy, tissue-engineered products, and others. The cell and gene therapy segment held the largest share of the market in 2019; whereas, the tissue engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the GMP cytokines market players to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
The List of Companies - GMP Cytokines Market
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.